Wall Street Zen upgraded shares of Cigna Group (NYSE:CI – Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Saturday morning,Wall Street Zen reports.
A number of other equities research analysts also recently weighed in on the company. Robert W. Baird set a $362.00 target price on Cigna Group in a research report on Friday, July 31st. Evercore assumed coverage on Cigna Group in a report on Wednesday, September 9th. They issued an “in-line” rating and a $290.00 price target for the company. Barclays raised their price objective on Cigna Group from $310.00 to $320.00 and gave the stock an “equal weight” rating in a research report on Monday, November 9th. Guggenheim lowered their price objective on Cigna Group from $361.00 to $347.00 and set a “buy” rating on the stock in a research report on Friday, November 6th. Finally, Sanford C. Bernstein upped their target price on Cigna Group from $387.00 to $390.00 and gave the company an “outperform” rating in a research note on Wednesday, November 11th. Fourteen analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat, Cigna Group presently has a consensus rating of “Moderate Buy” and an average price target of $337.35.
Read Our Latest Stock Report on CI
Cigna Group Price Performance
Shares of Cigna Group stock opened at $270.83 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.74. The company has a market cap of $71.36 billion, a PE ratio of 11.95, a price-to-earnings-growth ratio of 1.01 and a beta of 0.25. The firm has a fifty day moving average price of $288.03 and a two-hundred day moving average price of $282.99. Cigna Group has a fifty-two week low of $257.85 and a fifty-two week high of $318.05.
Cigna Group (NYSE:CI – Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The health services provider reported $7.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.52 by $0.46. The company had revenue of $73.79 billion for the quarter, compared to the consensus estimate of $72.64 billion. Cigna Group had a net margin of 2.09% and a return on equity of 19.57%. The business’s revenue was up 5.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $7.83 EPS. Analysts expect that Cigna Group will post 30.70 EPS for the current year.
Cigna Group Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Thursday, December 3rd will be paid a $1.56 dividend. The ex-dividend date of this dividend is Thursday, December 3rd. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. Cigna Group’s payout ratio is presently 27.54%.
Insiders Place Their Bets
In related news, insider Everett Neville sold 617 shares of the stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the transaction, the insider owned 5,053 shares of the company’s stock, valued at $1,435,304.65. This represents a 10.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Cigna Group
Institutional investors have recently added to or reduced their stakes in the stock. Mystic Asset Management Inc. acquired a new stake in shares of Cigna Group in the 2nd quarter valued at $2,808,000. KBC Group NV grew its holdings in shares of Cigna Group by 6.4% in the 2nd quarter. KBC Group NV now owns 380,034 shares of the health services provider’s stock worth $104,768,000 after purchasing an additional 22,978 shares during the last quarter. Nykredit A S bought a new stake in shares of Cigna Group in the 2nd quarter worth about $15,300,000. Sanctuary Advisors LLC acquired a new stake in shares of Cigna Group during the 2nd quarter worth about $11,043,000. Finally, TD Asset Management Inc increased its position in shares of Cigna Group by 4.8% during the 2nd quarter. TD Asset Management Inc now owns 249,966 shares of the health services provider’s stock worth $68,911,000 after purchasing an additional 11,471 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.
Key Cigna Group News
Here’s some of the latest news about CI:
- Positive Sentiment: A recent article raises the possibility that CI is undervalued following management’s UBS Healthcare Conference update, though the supplied article details do not specify the basis for that assessment. Cigna valuation discussion
- Neutral Sentiment: The Cigna Group Foundation announced $31.5 million in grants for community organizations across 10 states, supporting youth mental health, veterans, and people with complex health conditions. The announcement highlights community investment but provides no direct financial outlook update. Cigna Foundation grants
- Negative Sentiment: A proposed CMS rule would expand fraud oversight and reporting requirements across government health programs, raising regulatory and repayment concerns for managed-care stocks. Cigna sold its Medicare Advantage and Part D businesses in 2025, suggesting some of the pressure may reflect sector-wide sentiment rather than direct exposure. CMS rule and managed-care stocks
Cigna Group Company Profile
The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.
Further Reading
- Five stocks we like better than Cigna Group
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
